{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T15:34:27Z","timestamp":1726068867641},"reference-count":64,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":3741,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[1998,4]]},"abstract":"<jats:p>The incidence of transfusion\u2010associated hepatitis in the United States has fallen dramatically since the late 1960s. Where once the risks were so great that as many as one in three transfused patients contracted hepatitis, now they are infinitesimal. Many factors share responsibility for this accomplishment; however, two stand above the rest: (i) improved donor selection and screening criteria, especially elimination of paid blood donations; and (ii) major advances in testing for viral hepatitis carriers. Currently, four tests are used for the prevention of transfusion\u2010associated hepatitis: (i) hepatitis B surface antigen; (ii) hepatitis C virus antibody; (iii) hepatitis B core antibody; and (iv) alanine aminotransferase. The first two tests are largely responsible for the current low risks of transfusion\u2010associated hepatitis due to hepatitis B virus and hepatitis C virus of 1 in 63000 and 1 in 125000, per unit, respectively. To further reduce the risks of transfusion\u2010associated hepatitis will require the enhanced sensitivity provided by nucleic acid amplification techniques (e.g. polymerase chain reaction). Currently, however, no such tests are licensed and practical, automated, or inexpensive enough for individual blood donor screening. We have made such great strides in the prevention of transfusion\u2010transmitted hepatitis that background rates of viral hepatitis now greatly exceed the risk of transmission via transfusion. For this reason, while it may still be reasonable to consider a transfusion as a possible cause for hepatitis, it is imperative that many other possibilities (e.g., iatrogenic and other risk factors) be ruled out.<\/jats:p>","DOI":"10.1111\/j.1440-1746.1998.tb00663.x","type":"journal-article","created":{"date-parts":[[2008,3,11]],"date-time":"2008-03-11T00:46:23Z","timestamp":1205196383000},"page":"443-449","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Current risks of viral hepatitis from blood transfusions"],"prefix":"10.1111","volume":"13","author":[{"given":"CHRISTOPHER J","family":"GRESENS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PAUL V","family":"HOLLAND","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(05)80030-6"},{"key":"e_1_2_1_3_2","first-page":"847","volume-title":"Clinical Practice of Transfusion Medicine","author":"Dodd RY","year":"1996"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-4-431-68255-4_144"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1992.tb01210.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1990.30590296367.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197504102921502"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)90131-9"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304293281716"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198104233041701"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-4-488"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-6-733"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2523562"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2496467"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199208063270601"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.351196110893.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1995.tb02538.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.34994378281.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03440090052025"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606273342601"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.35695288765.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1996.36111297091735.x"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1988.28488265275.x"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/jcm.29.3.605-610.1991","article-title":"Characterization of a reduction\u2010sensitive factor from human plasma responsible for apparent false activity in competitive assays for antibody to hepatitis B core antigen","volume":"29","author":"Robertson EF","year":"1991","journal-title":"J. Clin. Micro."},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1001\/archinte.1993.00410190107012","article-title":"Significance of isolated hepatitis B core antibody in blood donors","volume":"153","author":"Schifman RB","year":"1993","journal-title":"Arch. Intern. Med."},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.35195090661.x"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.277.16.1268"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-4-431-68255-4_116"},{"key":"e_1_2_1_29_2","first-page":"51S","article-title":"A case of transmission of hepatitis C virus between sexual partners","volume":"36","author":"Capelli C","year":"1996","journal-title":"Transfusion"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/jama.1990.03450170079026","article-title":"Risk factors for acute non\u2010A, non\u2010B hepatitis in the United States and associated hepatitis C virus infection","volume":"264","author":"Alter MJ","year":"1990","journal-title":"JAMA"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199611213352115"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1001\/jama.1995.03530170054032","article-title":"Infectious disease testing for blood transfusions","volume":"274","author":"NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions","year":"1995","journal-title":"JAMA"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.7.1681.bloodjournal8571681"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1996.36996420752.x"},{"key":"e_1_2_1_35_2","unstructured":"MackeyJ LiptonKS.AABB Association Bulletin 95\u20136: Interim Changes to Standards.AABB News Briefs July. 1995."},{"key":"e_1_2_1_36_2","first-page":"23","article-title":"Transfusion\u2010acquired hepatitis A in a premature infant with secondary nosocomial spread in an intensive care nursery","volume":"140","author":"Azimi PH","year":"1986","journal-title":"Am. J. Dis Control"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1983.03340170039025"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199202000-00012"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1994.tb00970.x"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1984.03350190013011"},{"key":"e_1_2_1_41_2","doi-asserted-by":"crossref","unstructured":"SeebergS BrandbergA HermodssonS LarssonP LundgrenS.Hospital outbreak of hepatitis A secondary to blood exchange in a baby.Lancet1981;1155\u20136.","DOI":"10.1016\/S0140-6736(81)92318-7"},{"key":"e_1_2_1_42_2","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1001\/archinte.1984.00350200071011","article-title":"Transmission of hepatitis A by transfusion of blood products","volume":"144","author":"Sherertz RJ","year":"1984","journal-title":"Arch. Intern. Med."},{"key":"e_1_2_1_43_2","volume-title":"Standards for Blood Banks and Transfusion Services","author":"Menitove JE","year":"1997"},{"key":"e_1_2_1_44_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/cdli.3.3.247-256.1996","article-title":"Immunodiagnosis of viral hepatitides A to E and non\u2010A to E","volume":"3","author":"Yang G","year":"1996","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.1.229"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)98020-4"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606063342310"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703133361101"},{"key":"e_1_2_1_49_2","first-page":"229","article-title":"The GB viruses: Isolation, characterization, diagnosis, and epidemiology","volume":"2","author":"Simons JN","year":"1996","journal-title":"Viral Hepatitis Reviews"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601183340316"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703133361102"},{"key":"e_1_2_1_52_2","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/jama.1996.03540190035026","article-title":"Hepatitis C virus infection associated with administration of intravenous immune globulin","volume":"276","author":"Bresee JS","year":"1996","journal-title":"JAMA"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1996.36596282581.x"},{"key":"e_1_2_1_54_2","unstructured":"EpsteinJS. Communication to manufacturers of immune globulin products re: FDA's intent to \u2018begin testing for hepatitis C virus (HCV) RNA on all immunoglobulin products that have not undergone one or more validated viral inactivation or removal steps.\u2019 Rockville: Food and Drug Administration December 27 1994."},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91955-8"},{"key":"e_1_2_1_56_2","first-page":"29","article-title":"Hepatitis A among persons with hemophilia who received clotting factor concentrates: United States, September\u2010December, 1995","volume":"45","year":"1996","journal-title":"MMWR"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520150078041"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602293340901"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701163360304"},{"key":"e_1_2_1_60_2","first-page":"610","article-title":"Epidemiologic Notes and Reports. Nosocomial transmission of hepatitis B virus associated with a spring\u2010loaded fingerstick device: California","volume":"39","year":"1990","journal-title":"MMWR"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.277.14.1106"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602293340902"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90518-9"},{"key":"e_1_2_1_64_2","unstructured":"HollandPV.Risk of viral hepatitis from blood: status report. Proceedings of the IXth Triennial International Symposium on Viral Hepatitis and Liver Disease.1998; (in press)."},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7765"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.1998.tb00663.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.1998.tb00663.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T23:36:16Z","timestamp":1698449776000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.1998.tb00663.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["10.1111\/j.1440-1746.1998.tb00663.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.1998.tb00663.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,4]]},"assertion":[{"value":"2008-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}